Medication supply shortages have become a widespread industry concern. However, a considered RTSM design can prevent shortages from jeopardizing your study goals. In this webinar, we will review how a robust interactive response technology (IRT) system can address drug supply issues and outline the actions that can be taken to manage both expected and emergency drug shortages through:
- Planning – supply simulation can help you plan manufacturing campaigns and optimal supply chains with confidence, especially if you have limited supplies
- Designing – standard IRT design should manage drug expiration dates to keep drug wastage to a minimum, but there are many advanced supply management options you can also leverage to ensure the challenge of limited stock is prioritized
- Adapting – RTSM settings can be quickly adapted to help you manage unforeseen situations during trial execution, such as delayed batch manufacture
Real-world trial examples will be presented that demonstrate how an advanced IRT system supports your supply challenges, regardless of when or why they occur.
时间
2023 年 11 月 8 日
10AM-11AM ET
发言人
Malcolm Morrissey
Associate Director, Statistics and Product Support Services, Calyx
Malcolm Morrissey obtained a PhD in Statistical Inference in 2001 and since has had broad experience as a research associate, statistician, and manager in the pharmaceutical industry. He joined Calyx in 2005 and currently manages a team whose duties include supporting and developing randomization and medication management algorithms for clinical trials managed by IRT.
Sylvain Berthelot
Sr. Dir. Voice of Customer & Strategy
Sylvain has acquired extensive experience in IRT through various roles within Calyx over his 10+ years in the company. It allows him to grasp where IRT can make a difference based on the protocol design, and accordingly advise clinical trial teams what solution is the most suitable for each trial. Sylvain is a key member of the Calyx IRT product core team, acting as an advocate for end-users, as well as sharing his vision with the team to push the boundaries of IRT.
